Bridgeway Capital Management’s Armata Pharmaceuticals ARMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $84.9K | Hold |
44,682
| – | – | ﹤0.01% | 1095 |
|
|
2025
Q1 | $65.2K | Sell |
44,682
-25,000
| -36% | -$36.5K | ﹤0.01% | 1101 |
|
|
2024
Q4 | $129K | Sell |
69,682
-5,700
| -8% | -$10.5K | ﹤0.01% | 1080 |
|
|
2024
Q3 | $179K | Sell |
75,382
-15,000
| -17% | -$35.6K | ﹤0.01% | 1088 |
|
|
2024
Q2 | $249K | Sell |
90,382
-20,000
| -18% | -$55K | 0.01% | 1006 |
|
|
2024
Q1 | $461K | Hold |
110,382
| – | – | 0.01% | 948 |
|
|
2023
Q4 | $358K | Sell |
110,382
-50,000
| -31% | -$162K | 0.01% | 1023 |
|
|
2023
Q3 | $481K | Sell |
160,382
-33,300
| -17% | -$99.9K | 0.01% | 881 |
|
|
2023
Q2 | $221K | Hold |
193,682
| – | – | 0.01% | 1113 |
|
|
2023
Q1 | $323K | Hold |
193,682
| – | – | 0.01% | 988 |
|
|
2022
Q4 | $240K | Buy |
193,682
+80,000
| +70% | +$99.2K | 0.01% | 1041 |
|
|
2022
Q3 | $480K | Hold |
113,682
| – | – | 0.01% | 905 |
|
|
2022
Q2 | $442K | Hold |
113,682
| – | – | 0.01% | 908 |
|
|
2022
Q1 | $556K | Hold |
113,682
| – | – | 0.01% | 907 |
|
|
2021
Q4 | $623K | Sell |
113,682
-8,718
| -7% | -$47.8K | 0.01% | 923 |
|
|
2021
Q3 | $443K | Buy |
122,400
+9,000
| +8% | +$32.6K | 0.01% | 1071 |
|
|
2021
Q2 | $450K | Buy |
113,400
+65,000
| +134% | +$258K | 0.01% | 1096 |
|
|
2021
Q1 | $231K | Buy |
+48,400
| New | +$231K | ﹤0.01% | 1268 |
|